PROGRAM

Evening of August 19

Residence of the U.S. Ambassador to Sweden
Hosted by Mr. Mark Cameron, Acting Deputy Chief of Mission

5:30

Welcoming Reception
Choral Performance by Stockholm Academic Female Choir

Opening remarks
Barbro C. Ehnbom,
Founder and Chairman, Swedish-American Life Science Summit

7:30 p.m.

Gold Sponsor Dinner at Villa Täcka Udden
(by invitation only)
Hosted by Ms. Annika Falkengren
President & CEO, SEB

Morning of August 20

EY Headquarters
Hosted by Mr. Staffan Folin, Partner and Head of Life Sciences Nordics, EY

8:15 a.m.

Registration and Coffee

9:00 a.m.

Welcoming Remarks
Ms. Aida Hadzialic
Swedish Minister for Upper Secondary School, Adult Education and Training

9:10 a.m.

Setting the Stage - Infectious Diseases
Dr. Hans Rosling
Professor Emeritus, International Health, Karolinska Institutet & Founder, Gapminder

9:30 a.m.

Panel: How Good is our Defense Against Infections?

Moderator: Dr. Hans Wigzell,Professor, Immunology & Former President, Karolinska Institutet

Dr. Alexander von Gabain, Deputy Vice-Chancellor, Innovation & Commercial Outreach, Karolinska Institutet & Co-Founder, Intercell
Dr. Rino Rappuoli, Chief Scientist, GSK Vaccines
Dr. Otto Cars, Professor, Department of Medical Sciences, Uppsala University
Dr. Hans Rosling, Professor Emeritus, International Health, Karolinska Institutet & Founder, Gapminder

10:40 a.m.

Company Presentations and Coffee
Bactiguard: Mr. Christian Kinch, CEO
Co-Diagnostics: Mr. Dwight Egan, CEO
Kancera: Dr. Thomas Olin, Founder & CEO

11:40 a.m.

Hot Chair: Value-Based Healthcare

Moderator:Dr. Stefan Larsson, Senior Partner & Managing Director, BCG

Dr. Melvin Samsom, Director, Karolinska University Hospital
Dr. William A. Haseltine, Chairman & President, ACCESS Health International

12:30 p.m.

Working Luncheon

Musical Performance

1:45 p.m.

Keynote - Genome Engineering with CRISPR-Cas9
Dr. Emmanuelle Charpentier
Professor, Helmholtz Centre for Infection Research

2:10 p.m.

New Frontiers versus Commercial Reality in Immune Oncology
Ms. Kristin Pothier
Partner & Managing Director, Head of Life Sciences, Parthenon-EY

2:30 p.m.

Company Presentations and Coffee
ACCESS Health International: Dr. William A. Haseltine, Chairman & President
Glionova: Dr. Eugen Steiner, CEO
PledPharma: Dr. Håkan Åström, Chairman

3:30 p.m.

Panel: Managing the New Paradigm in Cancer Advancements

Moderator: Dr. Thomas Helleday, Professor, SciLifeLab, Karolinska Institutet

Dr. Susan Galbraith, VP Oncology & Head of Oncology Innovative Medicine Unit, AstraZeneca
Dr. Carl Borrebaeck, Professor & Deputy Vice-Chancellor, Lund University
Dr. Håkan Åström, Chairman, PledPharma
Dr. Emmanuelle Charpentier, Professor, Helmholtz Centre for Infection Research

4:30 p.m.

Summarizing the Day
Dr. Eugen Steiner,
Partner, HealthCap

Evening of August 20

M/S Riddarholmen

Hosted by Dr. Stefan Larsson, Senior Partner & Managing Director, BCG

7:00 p.m.

Dinner Cruise departing from Skeppsbrokajen

Morning of August 21

Nasdaq Stocockholm Headquarters

Hosted by Mr. Adam Kostyál, SVP of Listing Services, Europe, Nasdaq

8:15 a.m.

Registration and Coffee

8:50 a.m.

Introductory Remarks & Bell Ringing

9:05 a.m.

Science & Innovation within Life Science
Mr. Daniel Forslund
Commissioner for Innovation & eHealth, Stockholm Regional Council

9:20 a.m.

Special Guest Speaker - New Models for a Strengthened Life Science Ecosystem
Mr. Jan-Olof Jacke
President, AstraZeneca AB

9:40 a.m.

Panel: The Valley of Death - Financing of Early Stage Life Science

Moderator: Ms. Eva Redhe Ridderstad, Chairman, Spago Nanomedical

Dr. Göran Sandberg, Executive Director, Knut & Alice Wallenberg Foundation
Dr. Mathias Uhlén, Professor, KTH & Director, Human Protein Atlas
Dr. Yuval Binur, Managing Partner, Orchestra Medical Ventures
Dr. Francesco De Rubertis, Co-Founder & General Partner, Index Ventures
Mr. Adam Kostyál, SVP of Listing Services, Europe, Nasdaq

10:50 a.m.

Company Presentations and Coffee
Atlas Antibodies: Ms. Marianne Hansson, Co-Founder & CEO
Medivir: Mr. Niklas Prager President & CEO
Vironova: Mr. Mohammed Homman Founder & CEO

11:50 a.m.

Spotlight: Entrepreneurship in Life Science
Dr. Florence Haseltine Founder, Society for Women's Health
Dr. Karin Hehenberger, Founder & CEO, Lyfebulb
Ms. Sana Alajmovic, Co-Founder & CEO, Sigrid Therapeutics

12:15 p.m.

Rising Stars Exhibit
1928 Diagnostics
Cell Machines
Enteromics
Gradientech
Immuneed
Immunovia
Infant Bacterial Therapeutics
MoreInx
Spago Nanomedical

1:15 p.m.

Concluding Luncheon
Summarizing SALSS 2015
Dr. Håkan Björklund, Chairman, Lundbeck

SPECIAL EVENT LYFEBULB

Hotel Diplomat, Strandvägen 7C
Hosted by Dr. Karin Hehenberger, Founder & CEO, Lyfebulb

(see separate invitation)

3:00 p.m.

Combatting Chronic Diseases through Venture Philantropy and Social Connectivity

Evening of August 21

18th Century Royal Theatre Confidencen, Ulriksdals Slott

7:00 p.m.

Clarinet and String Concert
Hosted by Mr. Marcus Forss